Literature DB >> 16705690

Prolonged down regulation of specific gene expression in nucleus pulposus cell mediated by RNA interference in vitro.

Kenichiro Kakutani1, Kotaro Nishida, Koki Uno, Toru Takada, Takatoshi Shimomura, Koichiro Maeno, Masahiro Kurosaka, Minoru Doita.   

Abstract

To investigate the efficacies and the longevity of RNA interference in nucleus pulposus cells from rat and human, two reporter luciferase plasmids (Firefly and Renilla) were used. These plasmids were cotransfected with siRNA targeting Firefly luciferase to the nucleus pulposus cells extracted from Sprague Dawley rats and scoliosis patients. The inhibitory effects were evaluated by dual luciferase assay for 3 weeks. Proliferation activity of fibroblast-like cells extracted from the subcutaneous tissue of Sprague Dawley rats and the nucleus pulposus cells were measured by proliferation assay (WST-8 assay) every 2 days after plating. The expression of Firefly luciferase was drastically inhibited both in rats (94.7%) and in humans (93.7%). The inhibitory effects were maintained for 2 weeks and had disappeared completely by 3 weeks. The proliferation activity of nucleus pulposus cells was significantly lower than fibroblast-like cells. We have shown, for the first time, siRNA-mediated gene silencing in rat and human disc cells for a relatively sustained period, probably due to the stability of the nucleus pulposus cells in terms of cell proliferation. The demonstration of this study may allow further exploration of the use of siRNA for scientific research and the treatment of disc degenerative diseases. (c) 2006 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705690     DOI: 10.1002/jor.20171

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  7 in total

1.  Sustained long-term RNA interference in nucleus pulposus cells in vivo mediated by unmodified small interfering RNA.

Authors:  Teppei Suzuki; Kotaro Nishida; Kenichiro Kakutani; Koichiro Maeno; Takashi Yurube; Toru Takada; Masahiro Kurosaka; Minoru Doita
Journal:  Eur Spine J       Date:  2009-01-14       Impact factor: 3.134

Review 2.  Gene therapy approach for disc degeneration and associated spinal disorders.

Authors:  Kotaro Nishida; Teppei Suzuki; Kenichiro Kakutani; Takashi Yurube; Koichiro Maeno; Masahiro Kurosaka; Minoru Doita
Journal:  Eur Spine J       Date:  2008-11-13       Impact factor: 3.134

3.  Expression of adiponectin receptors in human and rat intervertebral disc cells and changes in receptor expression during disc degeneration using a rat tail temporary static compression model.

Authors:  Yoshiki Terashima; Kenichiro Kakutani; Takashi Yurube; Toru Takada; Koichiro Maeno; Hiroaki Hirata; Shingo Miyazaki; Masaaki Ito; Yuji Kakiuchi; Yoshiki Takeoka; Ryosuke Kuroda; Kotaro Nishida
Journal:  J Orthop Surg Res       Date:  2016-11-22       Impact factor: 2.359

4.  Gene Therapy Approach for Intervertebral Disc Degeneration: An Update.

Authors:  Yoshiki Takeoka; Takashi Yurube; Kotaro Nishida
Journal:  Neurospine       Date:  2020-03-31

Review 5.  Non-viral Gene Delivery Methods for Bone and Joints.

Authors:  Benjamin Gantenbein; Shirley Tang; Julien Guerrero; Natalia Higuita-Castro; Ana I Salazar-Puerta; Andreas S Croft; Amiq Gazdhar; Devina Purmessur
Journal:  Front Bioeng Biotechnol       Date:  2020-11-19

6.  Lentiviral-mediated RNAi targeting caspase-3 inhibits apoptosis induced by serum deprivation in rat endplate chondrocytes in vitro.

Authors:  L Ding; J P Wu; G Xu; B Zhu; Q M Zeng; D F Li; W Lu
Journal:  Braz J Med Biol Res       Date:  2014-06-03       Impact factor: 2.590

Review 7.  Maintaining the silence: reflections on long-term RNAi.

Authors:  Koen Raemdonck; Roosmarijn E Vandenbroucke; Joseph Demeester; Niek N Sanders; Stefaan C De Smedt
Journal:  Drug Discov Today       Date:  2008-08-07       Impact factor: 7.851

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.